Yi-Hsin Chan Selected Research

Ischemic Stroke

1/2022	Oral Anticoagulant Use for Patients with Atrial Fibrillation with Concomitant Anemia and/or Thrombocytopenia.
10/2021	Effectiveness and Safety of Direct Oral Anticoagulants in an Asian Population with Atrial Fibrillation Undergoing Dialysis: A Population-Based Cohort Study and Meta-Analysis.
1/2021	Oral Anticoagulants and Antiplatelet Agents in Patients With Atrial Fibrillation and Concomitant Critical Limb Ischemia: A Nationwide Cohort Study.
1/2021	Oral anticoagulants in extremely-high-risk, very elderly (>90 years) patients with atrial fibrillation.
1/2021	Non-vitamin K antagonist oral anticoagulants and warfarin in atrial fibrillation patients with concomitant peripheral artery disease.
1/2021	Impact of the initial decline in estimated glomerular filtration rate on the risk of new-onset atrial fibrillation and adverse cardiovascular and renal events in patients with type 2 diabetes treated with sodium-glucose co-transporter-2 inhibitors.
12/2020	Off-label dosing of non-vitamin K antagonist oral anticoagulants and clinical outcomes in Asian patients with atrial fibrillation.
10/2020	Glycemic status and risks of thromboembolism and major bleeding in patients with atrial fibrillation.
1/2020	Major adverse cardiovascular and limb events in patients with diabetes and concomitant peripheral artery disease treated with sodium glucose cotransporter 2 inhibitor versus dipeptidyl peptidase-4 inhibitor.
1/2020	Direct Oral Anticoagulants in Atrial Fibrillation Patients With Concomitant Hyperthyroidism.

For more, sign up at right for free...

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Yi-Hsin Chan Research Topics

Disease

40	Atrial Fibrillation 10/2022 - 01/2016
29	Hemorrhage 10/2022 - 01/2016
21	Stroke (Strokes) 10/2022 - 01/2016
17	Ischemic Stroke 01/2022 - 01/2016
14	Embolism (Embolus) 10/2022 - 01/2016
11	Heart Failure 02/2021 - 10/2012
10	Myocardial Infarction 10/2021 - 01/2016
9	Thromboembolism 01/2021 - 10/2018
8	Chronic Renal Insufficiency 12/2021 - 11/2016
7	Type 2 Diabetes Mellitus (MODY) 07/2022 - 10/2020
7	Intracranial Hemorrhages (Intracranial Hemorrhage) 01/2022 - 01/2016
6	Diabetes Mellitus 01/2021 - 11/2016
5	Chronic Kidney Failure (Chronic Renal Failure) 10/2021 - 04/2016
5	Cardiac Arrhythmias (Arrythmia) 10/2021 - 10/2012
4	Ventricular Fibrillation 01/2021 - 10/2015
3	Hypertension (High Blood Pressure) 01/2022 - 11/2016
3	Neoplasms (Cancer) 10/2021 - 10/2020
3	Aortic Dissection 01/2021 - 01/2021
3	Peripheral Arterial Disease 01/2021 - 01/2020
3	Acute Kidney Injury (Acute Renal Failure) 08/2018 - 11/2016
3	Bundle-Branch Block (Fascicular Block) 06/2017 - 03/2013
2	COVID-19 01/2022 - 12/2021
2	Aortic Aneurysm (Aneurysm, Aortic) 10/2021 - 01/2021
2	Body Weight (Weight, Body) 01/2021 - 01/2021
2	Weight Loss (Weight Reduction) 01/2021 - 01/2021
2	Cardiovascular Diseases (Cardiovascular Disease) 11/2020 - 01/2016
2	Ischemia 01/2020 - 09/2016
2	Transient Ischemic Attack 01/2019 - 11/2016
2	Vascular Diseases (Vascular Disease) 01/2019 - 11/2016
2	Intracranial Embolism 01/2018 - 01/2016
1	Frailty 01/2022
1	Thrombocytopenia (Thrombopenia) 01/2022
1	Anemia 01/2022
1	Venous Thrombosis (Deep-Vein Thrombosis) 10/2021
1	Atrial Remodeling 10/2021
1	Heart Arrest (Cardiac Arrest) 01/2021
1	Chronic Limb-Threatening Ischemia 01/2021
1	Urinary Bladder Neoplasms (Bladder Cancer) 01/2021
1	Aortic Diseases 01/2021
1	Aneurysm (Aneurysms) 01/2021
1	Hematuria 01/2021
1	ST Elevation Myocardial Infarction 05/2020
1	Hyperthyroidism 01/2020
1	Myocardial Ischemia (Ischemic Heart Diseases) 01/2020
1	Liver Cirrhosis (Hepatic Cirrhosis) 01/2019

Drug/Important Bio-Agent (IBA)

27	AnticoagulantsIBA 10/2022 - 01/2016
26	Warfarin (Coumadin)FDA LinkGeneric 01/2022 - 01/2016
16	Vitamin K FDA Link 01/2022 - 01/2016
11	Dabigatran FDA Link 10/2021 - 01/2016
11	RivaroxabanIBA 10/2021 - 01/2016
6	Sodium-Glucose Transport ProteinsIBA 07/2022 - 01/2020
6	Glucose (Dextrose)FDA LinkGeneric 07/2022 - 01/2020
6	apixabanIBA 10/2021 - 01/2018
5	SodiumIBA 07/2022 - 01/2020
5	N(4)-oleylcytosine arabinosideIBA 10/2021 - 01/2019
4	CalciumIBA 01/2021 - 10/2015
4	omega-Chloroacetophenone (Mace)IBA 01/2021 - 01/2016
3	edoxabanIBA 10/2022 - 01/2019
3	Platelet Aggregation Inhibitors (Antiplatelet Drugs)IBA 01/2021 - 11/2017
3	Angiotensin-Converting Enzyme Inhibitors (ACE Inhibitors)IBA 01/2021 - 04/2016
3	Angiotensin Receptor AntagonistsIBA 01/2021 - 04/2016
3	ApaminIBA 01/2018 - 10/2015
3	PotassiumIBA 01/2017 - 10/2015
2	CreatinineIBA 07/2022 - 01/2021
2	Glucagon-Like Peptide-1 Receptor AgonistsIBA 01/2022 - 01/2022
2	Pharmaceutical PreparationsIBA 01/2022 - 12/2021
2	Hemoglobins (Hemoglobin)IBA 01/2022 - 11/2020
2	FluoroquinolonesIBA 10/2021 - 01/2021
2	Biomarkers (Surrogate Marker)IBA 01/2021 - 01/2021
1	2'- deoxythymidylyl- (3'- 5')- 2'- deoxyadenosine (d(AT))IBA 10/2021
1	TicagrelorIBA 10/2021
1	Clopidogrel (Plavix)FDA Link 10/2021
1	Aspirin (Acetylsalicylic Acid)FDA LinkGeneric 10/2021
1	Factor Xa InhibitorsIBA 10/2021
1	L-Type Calcium Channels (Dihydropyridine Receptor)IBA 10/2021
1	AntithrombinsIBA 10/2021
1	Dobutamine FDA LinkGeneric 02/2021
1	Simendan (Levosimendan)IBA 02/2021
1	Interleukin-17 (Interleukin 17)IBA 01/2021
1	AminopropionitrileIBA 01/2021
1	Insulin (Novolin)FDA Link 01/2021
1	CytokinesIBA 01/2021
1	DiureticsIBA 01/2021
1	Antihypertensive Agents (Antihypertensives)IBA 01/2021
1	APTIBA 01/2021
1	LumicanIBA 01/2021
1	Glycated Hemoglobin (Glycosylated Hemoglobin)IBA 10/2020
1	SymportersIBA 01/2020
1	Factor Xa (Coagulation Factor Xa)IBA 11/2019
1	Calcium-Calmodulin-Dependent Protein Kinase Type 2IBA 01/2019

Therapy/Procedure

6	Therapeutics 01/2022 - 01/2011
4	Cardiac Resynchronization Therapy 06/2017 - 03/2013
3	Stents 12/2021 - 10/2012
3	Surgical Amputation (Amputations) 01/2021 - 09/2016
2	Renal Dialysis (Hemodialysis) 10/2021 - 12/2018
1	Drug Therapy (Chemotherapy) 01/2022
1	Resuscitation 01/2021
1	Cardiopulmonary Resuscitation (CPR) 01/2021
1	Thrombectomy 05/2020
1	Percutaneous Coronary Intervention 05/2020